What is Biogen Pharmachem Industries Ltd (531752) share price return in the past 10 years?

Biogen Pharmachem Industries Ltd share price has appreciated 4.3% annually (CAGR) over the past ten years.

What is the share price of Biogen Pharmachem Industries Ltd (531752)?

Company share prices are keep on changing according to the market conditions. The current trading price of Biogen Pharmachem Industries Ltd (531752) on 04-Jun-2026 16:59:59 at 16:59 is 0.35.

What is the P/E ratio of Biogen Pharmachem Industries?

The latest standalone P/E ratio of Biogen Pharmachem Industries as of 04-Jun-2026 is 42.86.

What is the P/B ratio of Biogen Pharmachem Industries Ltd (531752)?

The latest standalone P/B ratio of Biogen Pharmachem Industries Ltd (531752) as of 04-Jun-2026 is 0.32.

What is the 52-week high and low of Biogen Pharmachem Industries Ltd (531752)?

The 52-week high of Biogen Pharmachem Industries Ltd (531752) is Rs. 0.93 and the 52-week low is Rs. 0.33.

Biogen Pharmachem Industries Ltd (531752) Share Analysis – Quality, Valuation Zone & Price Trend & DeciZen Rating

Name: Biogen Pharmachem Industries Ltd (531752)
Brand: Biogen Pharmachem Industries

Biogen Pharmachem Industries Ltd (531752)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 531752 NSE: Trading | Small Cap | Biogen Pharmachem Share Price

Biogen Pharmachem Industries Ltd (531752)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 531752 NSE: Trading | Small Cap | Biogen Pharmachem Share Price

Key Metrics

Valuation Multiples

Market Cap

₹37 Cr.

Current Price

₹0.4

52-Week Low / High

₹0 / 1

TTM EPS

₹0

TTM Sales

₹0 Cr.

Book Value per Share

₹1.1

P/E Ratio

42.86

Higher than its 5-year historical median

Industry PE

Price to Book (P/B)

0.32

Lower than its 5-year historical median

Price to Sales (P/S)

0.00

EV/EBITDA

38.18

In line with its 5-year historical median

Dividend Yield

0.00%

Profitability Efficiency

Return on Equity (ROE)

-0.52%

Underperforms industry median

Return on Capital Employed (ROCE)

-0.36%

Underperforms industry median

Return on Assets (ROA)

-0.39%

Operating Profit Margin

Net Profit Margin

Gross Profit Margin

Growth Momentum
1-yr vs 3-yr growth

Sales Growth (1 Year)

Operating Profit Growth (1 Year)

Net Profit Growth (1 Year)

-115.03%

Asset Quality

Promoter Holding

0.00%

Pledged shares (%) of Promoter's holding (%)

0.00%

Reserves

₹9 Cr.

Equity

₹105.3 Cr.

Face Value

₹1

All Time Low / High

₹0.01 / 16.03

Biogen Pharmachem Industries stock performance

Key Ratios

Check Before You Invest

M-Cap below 100cr DeciZen not available

Q.1 Is Biogen Pharmachem Industries Ltd a good quality company?

Biogen Pharmachem Industries Ltd is a quality company, based on a multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.

How does Biogen Pharmachem Industries Ltd performance compare with that of its Peers?

Q.1 Revenue growth of Biogen Pharmachem Industries Ltd vs industry peers?

Biogen Pharmachem Industries Ltd revenue CAGR is -100.00%, compared to the industry median CAGR of 4.99%, indicating slower growth and losing its market share.

Q.1 Promoter shareholding and pledge status of Biogen Pharmachem Industries Ltd?

Promoters hold 0.00% of the Biogen Pharmachem Industries Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Q.1 Stock return of Biogen Pharmachem Industries Ltd over the last decade?

Over the last 9 year(s), the stock has delivered a CAGR of 4% based on the current price.

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	-0%	-0.2%	-11.3%	-0%	-0.2%	-2.9%	-0%	0.8%	3.5%	-0.4%	-
Value Creation Index ⓘ	-1.0	-1.0	-1.8	-1.0	-1.0	-1.2	-1.0	-0.9	-0.8	-1.0	-
Growth Parameters ⓘ
Sales ⓘ	0	0	0	1	0	1.6	2.5	0	0	0	0
Sales YoY Gr.	-	NA	NA	NA	-100%	NA	52.5%	-100%	NA	NA	-
Adj EPS ⓘ	-0	-0	-0	0	-0	-0	0	-0	0	-0	0
YoY Gr.	-	NA	NA	NA	NA	NA	NA	NA	NA	-100%	-
BVPS (₹) ⓘ	0.8	0.8	0.7	0.7	0.7	0.7	0.7	0.7	0.7	0.7	1.1
Adj Net Profit ⓘ	-0	-0.1	-1.9	-0	-0.1	-0.5	0.2	-0	0.8	-0	1
Cash Flow from Ops. ⓘ	4.7	-0.1	-13.7	0.1	-1.2	4	1.4	1.7	1.9	-1.1	-
Debt/CF from Ops. ⓘ	1.3	-10.8	-0	7.2	-0.3	0	0	0	0	0	-

CAGR ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	NA	NA	-100%	NA
Adj EPS ⓘ	NA	NA	NA	-100%
BVPSⓘ	-0.9%	0.3%	1.4%	0%
Share Price	4.3%	13%	-14.5%	-56.8%

Key Financial Parameters ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	-0.1	-0.2	-3.3	-0	-0.2	-0.9	0.4	-0	1.5	-0.1	1.1
Op. Profit Mgn % ⓘ	0	0	0	-0.4	0	0.3	12	0	0	0	NAN
Net Profit Mgn % ⓘ	0	0	0	-0.4	0	-29.4	8.5	0	0	0	INF
Debt to Equity ⓘ	0.1	0	0	0	0	0	0	0	0	0	0
Working Cap Days ⓘ	0	0	0	19,937	0	10,617	6,835	0	0	0	0
Cash Conv. Cycle ⓘ	0	0	0	2,683	0	1,181	182	0	0	0	0

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	0	0	0	0.95	0	1.62	2.47	0	0	0
Operating Expenses ⓘ +	0.03	0.12	6.72	0.95	0.12	3.23	2.49	0.46	0.45	1.47
Manufacturing Costs	0	0	0	0	0	0	0	0	0	0
Material Costs	0	0	0	0.91	0	1.48	2.01	0	0	0
Employee Cost	0	0.01	0.03	0.04	0.04	0.01	0.05	0.17	0.08	0.17
Other Costs ⓘ	0.03	0.11	6.69	0.01	0.08	1.73	0.42	0.28	0.37	1.30
Operating Profit ⓘ	-0.03	-0.12	-6.72	-0	-0.12	-1.60	-0.02	-0.46	-0.45	-1.47
Operating Profit Margin (%)	-	-	-	-0.4%	-	-98.8%	-0.6%	-	-	-
Other Income ⓘ +	0	0	0.15	0	0	0	0.01	0.91	2.38	1.20
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	0
Interest ⓘ	0	0	0	0	0	0	0	0	0	0
Depreciation ⓘ	0	0	0	0	0	0	0	0	0	0
Profit Before Tax ⓘ	-0.03	-0.12	-6.56	-0	-0.12	-1.60	-0.01	0.46	1.93	-0.27
Tax ⓘ	0	0	0	0	0	0	0	0	0	0.02
Profit After Tax	-0.03	-0.12	-6.56	-0	-0.12	-1.60	-0.01	0.46	1.93	-0.29
PAT Margin (%)	-	-	-	-0.4%	-	-98.8%	-0.4%	-	-	-
Adjusted EPS (₹)	0.0	0.0	-0.1	0.0	0.0	-0.0	0.0	0.0	0.0	0.0
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Valuation of Biogen Pharmachem - Standalone

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	60.96	60.84	54.28	54.27	55.75	54.14	54.13	54.59	56.52	56.23
Share Capital ⓘ	65.26	65.26	65.26	65.26	65.26	65.26	65.26	65.26	65.26	65.26
Reserves ⓘ	-4.30	-4.42	-10.98	-10.99	-9.51	-11.12	-11.13	-10.67	-8.74	-9.03
Debt +	6.21	0.72	0.01	0.63	0.31	0	0	0	0	0
Long Term Debt	6.21	0.72	0.01	0.63	0.31	0	0	0	0	0
Short Term Debt	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	0	0	0	1.09	0	0.06	0	0	0	0
Others Liabilities ⓘ	1.64	1.69	1.64	1.64	0.04	0.05	0.82	0.24	0.30	35.79
Total Liabilities ⓘ	68.81	63.25	55.93	57.63	56.09	54.25	54.95	54.83	56.82	92.02
Fixed Assets
Net Fixed Assets ⓘ +	0	0	0	0	0	0	0	0	0	0
Gross Block	0	0	0	0	0	0	0	0	0	0
Accumulated Depreciation	0	0	0	0	0	0	0	0	0	0
CWIP ⓘ	0	0	0	0	0	0	0	0	0	0
Investments ⓘ	26.69	22.39	3.52	6.25	6.45	9.49	6.95	8.85	5.44	23.84
Inventories	0	0	0	0	0	0	0	0	0	0
Trade Receivables	0	0	7.03	8.03	8.03	2.54	0	0	0	0
Cash Equivalents	0.13	0.06	0.02	0	0	0.01	0.08	0.13	0.02	2.02
Others Assets ⓘ	41.98	40.79	45.36	43.35	41.62	42.21	47.91	45.85	51.36	66.16
Total Assets ⓘ	68.81	63.25	55.93	57.63	56.09	54.25	54.95	54.83	56.82	92.02

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	4.68	-0.07	-13.65	0.09	-1.21	3.95	1.40	1.70	1.94	-1.08
PBT ⓘ	-0.03	-0.12	-6.56	-0	-0.12	-1.60	-0.01	0.46	1.93	-0.29
Adjustment ⓘ	0	0	0	0	0	0	0	0	0	0
Changes in Working Capital ⓘ	4.71	0.05	-7.08	0.09	-1.1	5.55	1.41	1.25	0.01	-0.79
Tax Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Cash Flow From Investing Activity ⓘ +	17.08	4.30	14.32	-0.72	1.54	-3.64	-1.32	-1.66	-2.06	-32.62
Capex	0	0	0	0	0	0	0	0	0	0
Net Investments	17.08	4.30	18.88	-2.73	-0.20	-3.04	2.54	-1.90	3.41	-18.40
Others ⓘ	0	0	-4.56	2.01	1.74	-0.60	-3.86	0.24	-5.47	-14.22
Cash Flow From Financing Activity ⓘ +	-21.74	-4.31	-0.71	0.62	-0.32	-0.31	0	0	0	35.70
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	-1.45	1.18	0	0	0	0	0	0	0	0
Interest Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Dividend Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Others ⓘ	-20.29	-5.49	-0.71	0.62	-0.32	-0.31	0	0	0	35.70
Net Cash Flow ⓘ	0.02	-0.07	-0.03	-0.02	0	0	0.08	0.05	-0.11	2

Financial Ratio

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	-0.05	-0.2	-11.4	-0.01	-0.21	-2.92	-0.02	0.84	3.48	-0.52
ROCE (%)	-0.04	-0.19	-11.33	-0.01	-0.21	-2.91	-0.02	0.84	3.48	-0.36
Asset Turnover Ratio	0	0	0	0.02	0	0.03	0.05	0	0	0
PAT to CFO Conversion(x)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	3.7	1.01	N/A
Working Capital Days
Receivable Days	0	0	0	2,893.20	0	1,188.40	0	0	0	0
Inventory Days	0	0	0	0	0	0	0	0	0	0
Payable Days	0	0	0	218.80	0	15	0	0	0	0

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Biogen Pharmachem Industries Ltd FAQs

The current trading price of Biogen Pharmachem on 04-Jun-2026 16:59 is ₹0.35.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 03-Jun-2026 the market cap of Biogen Pharmachem stood at ₹36.86 Cr

The latest P/E ratio of Biogen Pharmachem as of 03-Jun-2026 is 42.86.

The latest P/B ratio of Biogen Pharmachem as of 03-Jun-2026 is 0.32.

The 52-week high of Biogen Pharmachem is ₹0.93 and the 52-week low is ₹0.33.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Biogen Pharmachem is ₹0.00 ( Cr.) .

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Biogen Pharmachem Industries Ltd is a below average quality company.

The key valuation ratios of Biogen Pharmachem Industries Ltd's currently when compared to its past seem to suggest it is in the Fair zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Biogen Pharmachem Industries Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

About Biogen Pharmachem Industries Ltd

Sun Techno Overseas Ltd., formerly Wellworth Overseas Limited, is an India-based company.In 2011 the company changed its name from Wellworth Overseas Ltd. to Sun Techno Overseas Ltd.

The company is engaged in the business of trading in shares and securities, small level of stock broking and consulting works. As of March 31, 2009, the company had started trading operations and business in commodities, both in agro-based and precious metals, and other goods in present and future markets.

The company is also diversifying its business activities in the power sector, by establishing wind power generation plant.

Biogen Pharmachem Industries Ltd (531752)

Biogen Pharmachem Industries Ltd (531752)

Biogen Pharmachem Industries stock performance

Check Before You Invest

M-Cap below 100cr DeciZen not available

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Biogen Pharmachem - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Biogen Pharmachem Industries Ltd FAQs

About Biogen Pharmachem Industries Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Biogen Pharmachem Industries Ltd (531752)

Biogen Pharmachem Industries Ltd (531752)

Biogen Pharmachem Industries stock performance

Check Before You Invest

M-Cap below 100cr DeciZen not available

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Biogen Pharmachem - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Biogen Pharmachem Industries Ltd FAQs

What is the share price of Biogen Pharmachem?

What is the market cap of Biogen Pharmachem?

What is the P/E ratio of Biogen Pharmachem?

What is the P/B ratio of Biogen Pharmachem?

What is the 52-week high and low of Biogen Pharmachem?

What is the TTM revenue of Biogen Pharmachem?

Is Biogen Pharmachem Industries Ltd a good quality company?

Is Biogen Pharmachem Industries Ltd undervalued or overvalued?

Is Biogen Pharmachem Industries Ltd a good buy now?

About Biogen Pharmachem Industries Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.